• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Burundi eliminates trachoma as a public health problem
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Health For All > Public Health > Burundi eliminates trachoma as a public health problem
Public Health

Burundi eliminates trachoma as a public health problem

ME Desk
ME Desk
Published: July 12, 2025
Share
5 Min Read
Burundi
SHARE

The World Health Organization (WHO) has validated Burundi as having eliminated trachoma as a public health problem, making it the eighth country in WHOโ€™s African Region to reach this important milestone. Trachoma is also the first neglected tropical disease (NTD) to be eliminated in the country.

Contents
  • Burundiโ€™s progress
  • Disease prevalence
  • Global progress

โ€œEliminating a disease like trachoma is a major public health achievement that requires sustained effort and dedication,โ€ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. โ€œI congratulate the government and the people of Burundi and commend them for their hard work and commitment. It is great to see Burundi join the growing group of countries that have eliminated at least one NTDโ€.

Also Read: WHO launches bold push to raise health taxes and save millions of lives

โ€œThis validation marks a major milestone in our commitment to health equityโ€, said Dr Lydwine Baradahana, Minister of Public Health and the Fight Against AIDS, Burundi. โ€œIt is a collective victory made possible by nearly 20 years of national mobilization and international solidarity. I thank all the partners, community actors and institutions in Burundi and beyond who made this historic achievement possibleโ€.

Burundiโ€™s progress

Before 2007, with no reported cases or epidemiological studies, the extent of trachoma endemicity in Burundi was largely unknown. That year, the country launched an initiative to tackle NTDs, which included integrated mapping of soil-transmitted helminthiases, schistosomiasis, lymphatic filariasis and trachoma. Following the mapping, the Ministry of Public Health and the Fight Against AIDS conducted further investigations. Baseline surveys carried out in 2009โ€“2010 confirmed that trachoma was endemic in parts of the country. This prompted introduction of interventions based on the WHO-recommended SAFE strategy for 2.5 million people who needed them across 12 health districts.

Burundiโ€™s trachoma elimination programme was supported technically and financially by CBM Christoffel Blindenmission, the END Fund, Geneva Global and WHO. The International Trachoma Initiative at the Task Force for Global Health donated azithromycin (Zithromax, Pfizer, New York NY, USA). WHO continues to support support the countryโ€™s health authorities to monitor communities in which trachoma was previously endemic to ensure there is no resurgence of the disease.

This achievement reflects the governmentโ€™s resolve to protect its most vulnerable populations. Under the leadership of the Ministry of Public Health and the Fight Against AIDS, and with the dedication of community health workers, support from key partners, and WHOโ€™s technical guidance, this success was made possibleโ€ said Dr Xavier Crespin, WHO Representative in Burundi. โ€œThis win inspires us to press forward with the same determination to eliminate all remaining neglected tropical diseases.โ€

Disease prevalence

Trachoma remains a public health problem in 32 countries with an estimated 103 million people living in areas requiring interventions against the disease. Trachoma is found mainly in the poorest and most rural areas of Africa, Central and South America, Asia, the Western Pacific and the Middle East.

The African Region is disproportionately affected by trachoma with 93 million people living in at-risk areas in April 2024, representing 90% of the global trachoma burden. Significant progress has been made in the fight against trachoma over the past few years and the number of people requiring antibiotic treatment for trachoma in the African Region fell by 96 million from 189 million in 2014 to 93 million as of April 2024, representing a 51% reduction.

Global progress

With todayโ€™s announcement, a total of 57 countries have now eliminated at least one NTD. Of these, 24โ€” (including Burundi)โ€”have successfully eliminated trachoma as a public health problem.ย Other countries that have reached this milestone include Benin, Cambodia, China, Gambia, Islamic Republic of Iran, Lao Peopleโ€™s Democratic Republic, Ghana, India, Iraq, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Togo, Vanuatu and Viet Nam.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Epsteinโ€“Barr New study reveals that Epsteinโ€“Barr virus infection may increase riskof a broad spectrum of cancer types
Next Article Charitรฉ and Siemens Charitรฉ and Siemens Healthineers jointly develop innovative concepts

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Burundi eliminates trachoma as a public health problem
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Burundi eliminates trachoma as a public health problem
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?